Credit Industriel ET Commercial Sells 45,117 Shares of LENSAR, Inc. $LNSR

Credit Industriel ET Commercial reduced its position in shares of LENSAR, Inc. (NASDAQ:LNSR) by 26.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 123,483 shares of the company’s stock after selling 45,117 shares during the period. Credit Industriel ET Commercial owned about 1.03% of LENSAR worth $1,525,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. JPMorgan Chase & Co. grew its holdings in LENSAR by 26.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,928 shares of the company’s stock worth $73,000 after acquiring an additional 1,254 shares during the last quarter. DCF Advisers LLC lifted its holdings in shares of LENSAR by 1.3% during the second quarter. DCF Advisers LLC now owns 119,217 shares of the company’s stock worth $1,570,000 after purchasing an additional 1,500 shares during the period. Envestnet Asset Management Inc. lifted its holdings in shares of LENSAR by 11.8% during the third quarter. Envestnet Asset Management Inc. now owns 15,277 shares of the company’s stock worth $189,000 after purchasing an additional 1,611 shares during the period. Draper Asset Management LLC grew its stake in shares of LENSAR by 4.9% in the second quarter. Draper Asset Management LLC now owns 41,985 shares of the company’s stock worth $536,000 after purchasing an additional 1,945 shares during the last quarter. Finally, Police & Firemen s Retirement System of New Jersey acquired a new stake in LENSAR in the second quarter valued at $34,000. Institutional investors own 40.15% of the company’s stock.

LENSAR Stock Performance

LENSAR stock opened at $12.23 on Monday. The stock has a market capitalization of $146.03 million, a price-to-earnings ratio of -2.79 and a beta of 0.69. LENSAR, Inc. has a 52-week low of $8.96 and a 52-week high of $17.31. The stock’s 50 day moving average price is $11.97 and its two-hundred day moving average price is $11.90.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Wall Street Zen raised LENSAR to a “hold” rating in a report on Friday, November 28th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of LENSAR in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, LENSAR currently has an average rating of “Reduce” and an average price target of $15.00.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.